Steven P. Rowe

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer

Ryan Phillips, William Y. Shi, Matthew P. Deek et al. · JAMA Oncology · 2020 · 1.1K citations · Full text

Medicine, Oncology, Urology +17

Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

Zsolt Szabó, Esther Mena, Steven P. Rowe et al. · Molecular Imaging and Biology · 2015 · 448 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Michael J. Morris, Steven P. Rowe, Michael A. Gorin et al. · Clinical Cancer Research · 2021 · 380 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with ¹⁸ F-DCFPyL in Prostate Cancer Patients (OSPREY)

Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe et al. · The Journal of Urology · 2021 · 372 citations · Full text

Medicine, Oncology, Radiology +17

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 368 citations · Full text

Medicine, Nuclear Medicine, Radiology +16